Patent · US Expired

Inhibitors of adenosine monophosphate deaminase

US5731432A · kind A · utility

15Cited by
1References
41Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 1994
Grant dateMar 24, 1998
Priority date
Expiry dateFeb 3, 2014

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel diazepine derivatives which selectively inhibit adenosine monophosphate deaminase and methods of preparing these compounds are provided. These compounds are useful in treating certain conditions in vivo which may be ameliorated by increased local concentrations of adenosine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.